Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on κ-opioid agonists in the mouse writhing assay
- 1 July 1994
- journal article
- Published by Springer Nature in Psychopharmacology
- Vol. 115 (3) , 311-319
- https://doi.org/10.1007/bf02245071
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Interaction of β‐funaltrexamine with [3H]cycloFOXY binding in rat brain: Further evidence that β‐FNA alkylates the opioid receptor complexSynapse, 1991
- Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brainPeptides, 1990
- Anatomy of CNS opioid receptorsTrends in Neurosciences, 1988
- Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonistsLife Sciences, 1987
- Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: Evidence for kappa receptor subtypesLife Sciences, 1986
- Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent ratsLife Sciences, 1984
- Multiple opiate receptors: Differential binding of μ, κ and δ agonistsNeuropharmacology, 1981
- Bremazocine: A potent, long-acting opiate kappa-agonistLife Sciences, 1980
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980
- Stereoisomeric 5,9-dimethyl-2'-hydroxy-2-tetrahydrofurfuryl-6,7-benzomorphans, strong analgesics with nonmorphinelike action profilesJournal of Medicinal Chemistry, 1975